academic article

• Sex Differences in Kidney Transplantation: Austria and the United States, 1978-2018..  Frontiers in medicine.  -. 2022
• Sex-Specific Differences in Mortality and Incident Dialysis in the Chronic Kidney Disease Outcomes and Practice Patterns Study..  Kidney international reports.  7:410-423. 2021
• Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018..  PloS one.  15:-. 2020
• Associations of Hemoglobin Levels With Health-Related Quality of Life, Physical Activity, and Clinical Outcomes in Persons With Stage 3-5 Nondialysis CKD..  Journal of Renal Nutrition.  30:404-414. 2020
• International variation in the management of mineral bone disorder in patients with chronic kidney disease: Results from CKDopps..  Bone.  -. 2019
• Prescription of renin-angiotensin-aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care..  Journal of clinical hypertension (Greenwich, Conn.).  21:991-1001. 2019
• Association between serum ferritin and mortality: findings from the USA, Japan and European Dialysis Outcomes and Practice Patterns Study..  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.  33:2234-2244. 2018
• Twice-Weekly Hemodialysis and Clinical Outcomes in the China Dialysis Outcomes and Practice Patterns Study..  Kidney international reports.  3:889-896. 2018
• US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States..  American journal of kidney diseases : the official journal of the National Kidney Foundation.  69:A7-A8. 2017
• Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS)..  American journal of kidney diseases : the official journal of the National Kidney Foundation.  69:266-277. 2016
• Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing..  Clinical journal of the American Society of Nephrology : CJASN.  10:1814-21. 2015